Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The Core Model
The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory that proposes a collaborative approach to resolving global health issues and improving the productivity of drug development. The model proposes that scientific collaboration does not occur in an unstructured manner, but actually takes place within a highly structured order where knowledge is transferred, integrated and finally translated into commercial products. An understanding of this model will help solve the global pharmaceutical industry ́s productivity problems and address important globa...
The World's Health Care Crisis
At present, human society is facing a health care crisis that is affecting patients worldwide. In the United States, it is generally believed that the major problem is lack of affordable access to health care (i.e. health insurance). This book takes an unprecedented approach to address this issue by proposing that the major problem is not lack of affordable access to health care per se, but lack of access to better, safer, and more affordable medicines. The latter problem is present not only in the United States and the developing world but also in countries with socialized health care systems, such as Europe and the rest of the industrialized world. This book provides a comparative analysis...
The World's Health Care Crisis
The World's Health Care Crisis: Geopolitical and Climate Change Challenges builds on the success of the author's previous volume. Unlike the previous volume, this new work shifts gears and focuses on other factors contributing to the global health care crisis, providing information on the new challenges the world is experiencing, such as COVID-19, massive world migration, overpopulation, threats of global famine, nuclear war, the emergence of new infectious diseases around the planet, climate change and their effects on health care.The target audience is broad and multidisciplinary, made up of professionals of health systems, biomedical innovation and global health supply chains investors and Directors in Chief; decision makers in public health, multilateral institutions in regulatory, legislative, and executive areas; researchers, health sciences students (bachelor and postgraduate); health economists, economist associations, pharmaco-economists and historians; leaders of health professions associations and related companies; as well as leaders of the pharmaceutical industry associations.
Bioscience Regulatory Law
The world is witnessing the big bang of scientific discovery, and biotech stocks are on fire! The bio-pharma industry employs over 4 million people just in the US. Potentially 100’s of new little biotech companies will develop new generations of medicines and medical devices while creating vast numbers of new millionaires. The new Masters of Bioscience Law & Technology Mini-MBA certificate program, provides leading edge business skills, and leadership training to help propel your career forward. In recent years entrepreneurship has been added to many MBA curriculums, but starting your own business doesn’t have to take two years in school and $100,000+ in tuition. To stimulate prospective leaders, this new program will encourage all applicants to be reviewed for scholarship opportunities. What are you waiting for! Now is the time to jump in! The Biotech “Gold Rush” is On! What are you waiting for?
Collaborative Innovation in Drug Discovery
Can academia save the pharmaceutical industry? The pharmaceutical industry is at a crossroads. The urgent need for novel therapies cannot stem the skyrocketing costs and plummeting productivity plaguing R&D, and many key products are facing patent expiration. Dr. Rathnam Chaguturu presents a case for collaboration between the pharmaceutical industry and academia that could reverse the industry's decline. Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships provides insight into the potential synergy of basing R&D in academia while leaving drug companies to turn hits into marketable products. As Founder and CEO of iDDPartners, focused on pharmaceutical in...
Health Care Systems Around the World
This concise reference provides a one-stop point of research that examines major aspects of health care systems for over 190 countries worldwide. In a consistent format, ten major health care categories are systematically examined for each country: 1. Emergency Health Services; 2. Costs of Hospitalization; 3. Costs of Drugs; 4. Major Health Issues; 5. Government Role in Health Care; 6. Insurance; 7. Access to Health Care; 8. Health Care Facilities; 9. Health Care Personnel (doctor level of training, etc.); and 10. Public Health Programs. The volume is organized in alphabetical order of country names. Each country is presented on a two- or three-page spread with the same descriptive and statistical content, allowing readers to compare health care systems from country to country. For example, a reader may compare costs of drugs in France versus the United States versus Canada. Each country spread will feature short entries on the ten health care categories accompanied by charts, table, and photos as appropriate. The work culminates as a unique and essential resource for pre-med and medical students, as well as researchers in sociology, economics, and the health management fields.
Joshua Flint
None
Principles of Gender-Specific Medicine
The announcement that we had decoded the human genome in 2000 ushered in a new and unique era in biomedical research and clinical medicine. This Third Edition of Principles of Gender-Specific Medicine focuses, as in the past two editions, on the essentials of sexual dimorphism in human physiology and pathophysiology, but emphasizes the latest information about molecular biology and genomic science in a variety of disciplines. Thus, this edition is a departure from the previous two; the editor solicited individual manuscripts from innovative scientists in a variety of fields rather than the traditional arrangement of sections devoted to the various subspecialties of medicine edited by section...
